•
Mar 31

Seres Therapeutics Q1 2025 Earnings Report

Expected Revenue:$16.7M
+6568.0% YoY
Expected EPS:$0.08
+122.2% YoY
Total Revenue
$0
0
Gross Profit
-$1.08M
Previous year: -$1.56M
-31.0%
Cash and Equivalents
$58.8M
Previous year: $111M
-47.1%
Free Cash Flow
$26.9M
Previous year: -$35.3M
-176.1%
Total Assets
$164M
Previous year: $341M
-51.9%

Seres Therapeutics

Seres Therapeutics